Startup in Raleigh focusing on lung disease raises $15.8M, wants a lot more

Aer Therapeutics,a startup focusing on lung disease and what it calls “a novel inhaled approach” for treatment, has closed on $15.8 million in funding from 23 investors. But the company wants a lot more.

Read More